V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005250 | 320003595 | 1.52 | 61.6 | Adjuvant (A) | 2014-12-26 | 2015-01-22 | Cetuximab 7 day (>Cycle 2) | N | N | 320016672 | CETUXIMAB |
| 320005251 | 320003596 | 1.64 | 45.9 | Palliative (P) | 2015-06-28 | 2015-07-05 | Liposomal Doxorubicin (Caelyx) | N | N | 320016675 | LIPOSOMAL DOXORUBICIN |
| 320005252 | 320006616 | 1.61 | 13.5 | Curative (C) | 2014-03-09 | 2014-03-21 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 320016685 | CISPLATIN + RT |
| 320005253 | 320003597 | 1.76 | 91.899 | Palliative (P) | null | 2014-01-07 | CISPLATIN + FLUOROURACIL | N | N | 320016696 | CISPLATIN + FLUOROURACIL |
| 320005254 | 320003598 | 1.74 | null | Palliative (P) | 2016-08-06 | 2019-07-07 | GEMCARBO | N | Y | 320016698 | GEMCARBO |
| 320005255 | 320005643 | 1.6 | 13.5 | Curative (C) | 2014-06-06 | 2014-06-13 | CETUXIMAB | 02 | N | 320016701 | CETUXIMAB |
| 320005256 | 320003601 | 1.7 | null | Palliative (P) | null | 2017-04-03 | GEMCARBO | N | N | 320016701 | GEMCARBO |
| 320005257 | 320003602 | 1.67 | null | Palliative (P) | 2014-01-17 | 2014-01-18 | Liposomal Doxorubicin (Caelyx) | 1 | N | 320016707 | LIPOSOMAL DOXORUBICIN |
| 320005258 | 320005645 | 1.87 | null | Palliative (P) | 2016-04-22 | 2016-05-06 | GemCarbo Days 1+8 | Y | null | 320016727 | GEMCARBO |
| 320005259 | 320003603 | 1.74 | 65.4 | Curative (C) | 2016-05-04 | 2016-06-01 | Cisplatin + Radiotherapy | N | N | 320016728 | CISPLATIN + RT |
| 320005260 | 320005646 | 1.84 | 75.6 | Palliative (P) | 2017-09-18 | 2017-10-08 | CISPLATIN + FLUOROURACIL | N | N | 320016729 | CISPLATIN + FLUOROURACIL |
| 320005261 | 320003605 | 1.55 | 75.9 | Palliative (P) | 2015-09-12 | 2015-09-12 | CARBOPLATIN + GEMCITABINE | 02 | Y | 320016730 | GEMCARBO |
| 320005262 | 320003606 | 1.67 | 109.8 | null | 2017-09-26 | 2017-11-11 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 320016730 | CISPLATIN + RT |
| 320005263 | 320003607 | 1.86 | 63.2 | Curative (C) | 2017-01-26 | 2017-01-30 | CISPLATIN + RT | Y | N | 320016767 | CISPLATIN + RT |
| 320005264 | 320003608 | 1.73 | null | Disease modification (D) | 2011-11-21 | 2014-07-18 | Cisplatin | null | null | 320016767 | CISPLATIN |
| 320005265 | 320003609 | 1.68 | null | Adjuvant (A) | 2016-05-22 | 2016-06-03 | GemCarbo Days 1+8 | N | N | 320016771 | GEMCARBO |
| 320005266 | 320003610 | 1.82 | 70.8 | Adjuvant (A) | 2014-10-31 | 2014-11-24 | Cisplatin + Radiotherapy | N | null | 320016783 | CISPLATIN + RT |
| 320005267 | 320003611 | 1.72 | 82 | Curative (C) | 2014-07-02 | 2014-07-27 | Cisplatin + Radiotherapy | N | null | 320016794 | CISPLATIN + RT |
| 320005268 | 320005650 | 1.65 | 26.2 | Adjuvant (A) | 2017-08-18 | 2017-09-01 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320016797 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005269 | 320005650 | 1.63 | null | Curative (C) | 2018-07-14 | 2018-07-18 | CETUXIMAB | N | N | 320016797 | CETUXIMAB |
| 320005270 | 320003612 | 1.61 | 86.3 | Curative (C) | 2013-04-03 | 2013-05-04 | GEMCARBO | 02 | Y | 320016805 | GEMCARBO |
| 320005271 | 320003613 | 1.71 | 79.7 | Adjuvant (A) | 2017-12-13 | 2017-12-13 | Carboplatin + Liposomal Doxorubicin | null | Y | 320016815 | CARBOPLATIN + LIPOSOMAL DOX |
| 320005272 | 320003614 | null | 74.2 | Palliative (P) | 2015-12-16 | 2015-12-16 | Cisplatin + Modified de Gramont | N | N | 320016824 | CISPLATIN + FLUOROURACIL |
| 320005273 | 320003615 | null | 59.9 | Palliative (P) | 2014-07-30 | 2014-08-06 | GEMCARBO | N | N | 320016855 | GEMCARBO |
| 320005274 | 320003616 | 1.61 | null | null | 2017-07-09 | 2017-07-24 | Trial Unspecified | N | N | 320016861 | TRIAL |
| 320005275 | 320003617 | null | 137 | Neo-adjuvant (N) | 2016-08-07 | 2016-08-15 | Trial Unspecified | N | null | 320016881 | TRIAL |
| 320005276 | 320003618 | 1.47 | 63.35 | Palliative (P) | 2018-08-17 | 2018-08-18 | Liposomal Doxorubicin (Caelyx) | 2 | N | 320016894 | LIPOSOMAL DOXORUBICIN |
| 320005277 | 320003618 | 1.54 | 55.8 | Palliative (P) | 2017-01-01 | 2017-04-03 | null | N | N | 320016894 | NOT MATCHED |
| 320005278 | 320003619 | null | null | null | 2019-03-05 | 2019-03-14 | Trial Unspecified | N | Y | 320016924 | TRIAL |
| 320005279 | 320003619 | null | 65.2 | Adjuvant (A) | 2016-08-26 | 2016-08-26 | null | N | N | 320016924 | NOT MATCHED |
| 320005280 | 320003619 | 1.62 | 50 | Neo-adjuvant (N) | 2017-05-14 | 2017-05-24 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320016924 | CISPLATIN + RT |
| 320005281 | 320003619 | 1.7 | 77.8 | Neo-adjuvant (N) | 2014-12-28 | 2014-12-29 | GemCarbo Days 1+8 | N | null | 320016924 | GEMCARBO |
| 320005282 | 320003619 | 1.79 | 46.5 | Palliative (P) | 2016-09-09 | 2016-09-13 | Liposomal Doxorubicin (Caelyx) | N | null | 320016924 | LIPOSOMAL DOXORUBICIN |
| 320005283 | 320003619 | 1.56 | 45.9 | Curative (C) | 2017-02-04 | 2017-02-09 | CISPLATIN + RT | N | N | 320016924 | CISPLATIN + RT |
| 320005284 | 320003619 | 1.55 | 65.1 | Curative (C) | null | 2013-04-29 | Cisplatin 100 + RT(H&N) 1 day | N | N | 320016924 | CISPLATIN + RT |
| 320005285 | 320003619 | 1.56 | 70 | Palliative (P) | 2016-08-05 | 2016-08-18 | STS Rhabdo VIT0910 Vinc Irino Temoz | 2 | N | 320016924 | NOT MATCHED |
| 320005286 | 320003620 | 1.88 | 92 | Curative (C) | 2017-03-09 | 2017-04-06 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 320017000 | CISPLATIN + RT |
| 320005287 | 320003621 | 1.55 | 48.9 | Curative (C) | 2015-03-30 | 2015-04-05 | Cisplatin + Radiotherapy | 02 | N | 320017004 | CISPLATIN + RT |
| 320005288 | 320003621 | 1.47 | 71 | Palliative (P) | 2017-03-22 | 2017-03-22 | CISPLATIN + FLUOROURACIL | 02 | N | 320017004 | CISPLATIN + FLUOROURACIL |
| 320005289 | 320005658 | 1.46 | 88 | Not known (9) | 2013-12-20 | 2014-01-11 | CISPLATIN + FLUOROURACIL | N | Y | 320017016 | CISPLATIN + FLUOROURACIL |
| 320005290 | 320005658 | 1.76 | 58.6 | Palliative (P) | 2015-09-06 | 2015-09-13 | GEMCARBO | N | N | 320017016 | GEMCARBO |
| 320005291 | 320003623 | 1.71 | 56.6 | Palliative (P) | null | 2014-12-30 | CETUXIMAB | N | N | 320017052 | CETUXIMAB |
| 320005292 | 320003623 | 1.64 | 58.1 | Neo-adjuvant (N) | 2017-08-12 | 2017-08-18 | null | null | null | 320017052 | NOT MATCHED |
| 320005293 | 320003624 | 1.73 | 67.8 | Palliative (P) | null | 2017-09-01 | CETUXIMAB | N | N | 320017087 | CETUXIMAB |
| 320005294 | 320003626 | 1.67 | 74 | Palliative (P) | 2014-04-16 | 2014-04-17 | EW EuroEwing 2012 Arm B VDC | null | null | 320017094 | TRIAL |
| 320005295 | 320003628 | 1.52 | 53.6 | Neo-adjuvant (N) | 2016-08-27 | 2016-09-13 | Cisplatin 7 day | N | N | 320017098 | CISPLATIN |
| 320005296 | 320005662 | 1.52 | 93.6 | Curative (C) | 2017-07-09 | 2017-07-29 | Cisplatin + Radiotherapy | N | N | 320017105 | CISPLATIN + RT |
| 320005297 | 320006624 | 1.56 | 55.4 | Adjuvant (A) | 2015-08-03 | 2015-09-01 | Cisplatin + Radiotherapy | 02 | N | 320017115 | CISPLATIN + RT |
| 320005298 | 320006624 | 1.56 | 66.2 | Palliative (P) | 2015-02-13 | 2015-03-15 | GemCarbo Days 1+8 | Y | N | 320017115 | GEMCARBO |
| 320005299 | 320003629 | null | 46 | null | 2016-06-11 | 2016-06-13 | Trial Unspecified | 02 | N | 320017120 | TRIAL |